Chronic lymphocytic leukemia (CLL) is a type of cancer that can take a very different course with different patients. That’s why it is very difficult for physicians to predict the course of this disease. Researchers at the Center for Integrated Oncology in Cologne, Germany, have now developed a tool to help physicians with this task.